These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 25234560)

  • 1. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary.
    Jacobson TA; Ito MK; Maki KC; Orringer CE; Bays HE; Jones PH; McKenney JM; Grundy SM; Gill EA; Wild RA; Wilson DP; Brown WV
    J Clin Lipidol; 2014; 8(5):473-88. PubMed ID: 25234560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.
    Jacobson TA; Ito MK; Maki KC; Orringer CE; Bays HE; Jones PH; McKenney JM; Grundy SM; Gill EA; Wild RA; Wilson DP; Brown WV
    J Clin Lipidol; 2015; 9(2):129-69. PubMed ID: 25911072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What's next for dyslipidemia management? The 2013 ACC/AHA Guidelines, the NLA recommendations, and beyond.
    Waite LH; Phan YL; Spinler SA
    J Am Pharm Assoc (2003); 2016; 56(3):284-92. PubMed ID: 27156942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.
    Jacobson TA; Maki KC; Orringer CE; Jones PH; Kris-Etherton P; Sikand G; La Forge R; Daniels SR; Wilson DP; Morris PB; Wild RA; Grundy SM; Daviglus M; Ferdinand KC; Vijayaraghavan K; Deedwania PC; Aberg JA; Liao KP; McKenney JM; Ross JL; Braun LT; Ito MK; Bays HE; Brown WV; Underberg JA;
    J Clin Lipidol; 2015; 9(6 Suppl):S1-122.e1. PubMed ID: 26699442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia.
    ; Grundy SM
    J Clin Lipidol; 2013; 7(6):561-5. PubMed ID: 24314355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia: management using optimal lipid-lowering therapy.
    Ito MK
    Ann Pharmacother; 2012 Oct; 46(10):1368-81. PubMed ID: 23032652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Lipid Association Annual Summary of Clinical Lipidology 2015.
    Bays HE; Jones PH; Brown WV; Jacobson TA;
    J Clin Lipidol; 2014; 8(6 Suppl):S1-36. PubMed ID: 25523435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia.
    Ali YS; Linton MF; Fazio S
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):142-6. PubMed ID: 18316949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The recent national lipid association recommendations: how do they compare to other established dyslipidemia guidelines?
    Flink L; Underberg JA; Newman JD; Gianos E
    Curr Atheroscler Rep; 2015 Apr; 17(4):494. PubMed ID: 25690588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia: executive summary.
    Expert Panel on Dyslipidemia
    Atherosclerosis; 2014 Feb; 232(2):410-3. PubMed ID: 24468156
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of expert consensus to improve atherogenic dyslipidemia management.
    Millán Núñez-Cortés J; Pedro-Botet J; Brea-Hernando Á; Díaz-Rodríguez Á; González-Santos P; Hernández-Mijares A; Mantilla-Morató T; Pintó-Sala X; Simó R
    Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):36-44. PubMed ID: 24774262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical management considerations for dyslipidemia in HIV-infected individuals.
    Kirchner JT
    Postgrad Med; 2012 Jan; 124(1):31-40. PubMed ID: 22314112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of obtaining national cholesterol education program adult treatment panel III goals for all major serum lipoproteins after initiation of lipid altering therapy.
    Nichols GA; Ambegaonkar BM; Sazonov V; Brown JB
    Am J Cardiol; 2009 Dec; 104(12):1689-94. PubMed ID: 19962476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colesevelam hydrochloride in the management of dyslipidemia.
    Armani A; Toth PP
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):283-91. PubMed ID: 16716090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Cholesterol Guidelines for the Management of Atherosclerotic Cardiovascular Disease Risk: A Comparison of the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines with the 2014 National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia.
    Adhyaru BB; Jacobson TA
    Endocrinol Metab Clin North Am; 2016 Mar; 45(1):17-37. PubMed ID: 26892995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New cholesterol guidelines for the management of atherosclerotic cardiovascular disease risk: a comparison of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines with the 2014 National Lipid Association recommendations for patient-centered management of dyslipidemia.
    Adhyaru BB; Jacobson TA
    Cardiol Clin; 2015 May; 33(2):181-96. PubMed ID: 25939292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.
    Stone NJ; Robinson JG; Lichtenstein AH; Goff DC; Lloyd-Jones DM; Smith SC; Blum C; Schwartz JS;
    Ann Intern Med; 2014 Mar; 160(5):339-43. PubMed ID: 24474185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East.
    Al Sayed N; Al Waili K; Alawadi F; Al-Ghamdi S; Al Mahmeed W; Al-Nouri F; Al Rukhaimi M; Al-Rasadi K; Awan Z; Farghaly M; Hassanein M; Sabbour H; Zubaid M; Barter P
    Int J Cardiol; 2016 Dec; 225():268-283. PubMed ID: 27741487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.